Annual report pursuant to Section 13 and 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.21.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Consolidated net sales $ 14,514 $ 9,876
Cost of sales 9,908 7,261
Total Depreciation expense 449 82
Operating and other expenses 6,806 5,639
Total loss from continuing operations, before income taxes (2,326) (3,106)
Income (Loss) from discontinued operations, before income taxes 201 (40)
Net Loss (2,125) (3,146)
Total assets 31,405 12,274
Diagnostic Services [Member]    
Consolidated net sales 1,277
Total Depreciation expense 110
Total loss from continuing operations, before income taxes (344)
Total assets 13,410
Consumer Products [Member]    
Consolidated net sales 13,237 9,876
Total Depreciation expense 16 82
Total loss from continuing operations, before income taxes 1,962 2,533
Total assets 6,261 5,872
Unallocated Corporate [Member]    
Total loss from continuing operations, before income taxes (3,944) (5,639)
Total assets $ 11,734 $ 6,402